AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2022
Aug 2, 2022
30136_dirs_2022-08-02_c4893f34-41e6-4fa7-badf-3f31b0414916.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2022-07-29
Reporting Person: Begor Mark W (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-07-29 | Common Stock | A | 23934.0000 | $0.0000 | Acquired | 103798.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-07-29 | Stock Option/Right to Buy | $250.6900 | A | 48281.0000 | Acquired | 2030-07-29 | Common Stock (48281.0000) | Direct |
| 2022-07-29 | Stock Option/Right to Buy | $229.8000 | A | 43440.0000 | Acquired | 2030-07-29 | Common Stock (43440.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20382.0000 | Indirect |
| Common Stock | 40000.0000 | Indirect |
| Common Stock | 35383.0000 | Indirect |
Footnotes
F1: Special equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock vests 100% on 12/31/2025.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3: Special equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 12/31/2025.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26